SMART NANOVIRUS LIMITEDActive

Company number 14217792Private limited companyIncorporated 2022

Key figures

£1,245-94.6%
Net assets 2024/25
+68.8%
Average annual growth 2022/23–2024/25
010 k20 k30 k2022/232023/242024/25

Like most small UK companies, SMART NANOVIRUS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
020 k40 k2022/232023/242024/25
Filed accounts2022/23–2024/25
2022/232023/242024/25
Total assets43730,66914,324
Total liabilities—6,48611,829
Net assets / total equity43722,9331,245
Average number of employees111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: SMART NANOVIRUS LIMITED

Company

SMART NANOVIRUS LIMITED is a private limited company registered with Companies House under company number 14217792. It was incorporated on 6 Jul 2022. Its status is active. The registered office is in High wycombe (HP12). Its nature of business (SIC 2007) is manufacture of basic pharmaceutical products (21100).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files micro-entity accounts. Net assets were £1,245, down 94.6% on the previous year. Total assets were £14,324 and total liabilities £11,829. The company had an average of 1 employee. Figures are available for 3 financial years (2022/23–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 10 Jun 2027.